US Stock MarketDetailed Quotes

MNKD MannKind

Watchlist

5.060
-0.160-3.07%

Close Mar 26 16:00 ET

5.020
-0.040-0.79%

Post 20:01 ET

1.54BMarket Cap50.60P/E (TTM)

MannKind Stock Forum

Teddy123

Mar 10 18:21

MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

$MannKind (MNKD.US)$
MannKind Showcases Efficacy, Safety, and Mealtime Control Data from Recent Pediatric and Adult Studies of Afrezza® at the ATTD Conference, March 19-22

Stock_Drift

Dec 16, 2024 19:17

$MannKind (MNKD.US)$

Jaguar8

Dec 16, 2024 19:09

NEWS

$MannKind (MNKD.US)$
MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)
4 minutes ago, 3:05 AM PST
Via GlobeNewswire
Company plans to meet with FDA regarding potential sNDA submission in 1H 2025
Call planned today at 8:30 a.m. (ET) to discuss company's diabetes program progression
MannKind (MNKD) announced six-month results from its Phase 3 INHALE-1 study of Afrezza (inhaled insulin) in children and adolescents aged 4-17...

BelleWeather

Nov 22, 2024 19:30

Housekeeping continued…

Surpassed target price and am focusing elsewhere.

Share Your Profit/Loss

BelleWeather

Oct 26, 2024 03:15

Scaling out

of LETFs and contracts…

Share Your Profit/Loss

BelleWeather

Oct 19, 2024 10:03

MannKind

I think this company still has room to grow and may be undervalued, however it is next to being scaling out for other opportunities as the space is crowded and many new therapies have advanced.

Share Your Profit/Loss

BelleWeather

Sep 24, 2024 05:26

Trading Plan on Shares

I think $United Natural Foods (UNFI.US)$
is still undervalued. Originally purchased as a longterm hold, I intend to sell instead at ~25 USD and put the capital toward other trades, likely CSPs focusing on other equities for longterm holds.
A speculative hold for the longterm, though may take profit if another opportunity beckons. This is the same approach as to $MannKind (MNKD.US)$ and $Iovance Biotherapeutics (IOVA.US)$ :
Two speculative positions that I am building (similar ...

Share Your Profit/Loss

BelleWeather

Sep 19, 2024 00:54

MannKind Calls

These calls performed well in theory, but I was unable to get a fill at maximum profit, which was about 90%. I’ve learned a realted lesson a few times. It’s key to trade options with a great deal of liquidity. (Or pay a fee for more obscure tickers, in order to get a more beneficial fill.) I now largely trade more popular contracts and use LEAPS to speculate in the longer term on less heavily traded equities; treating them as less capital intensive share proxies, to be traded at a ...